Resultados de la búsqueda 1111-1120 of 11256 for anti-TNF drugs
The names of the study drugs ... Drugs used in chemotherapy, such as carboplatin ... PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ...
Treatment In Thoracic Aortic Aneurysm: Surgery Vs Surveillance. Rochester, Minn. The ascending aorta conducts blood from the heart to the rest of the body. The ...
... treatment with drugs that contain the metal platinum but then comes back within a certain period (recurrent platinum-resistant). Abemaciclib may stop the ...
Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as ...
The data collected from this study will help facilitate research on proton beam radiation therapy and allow for collaborative research. The PPCR will ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study To ...
The purpose of this study is to establish a prospective, standardized data collection for the patients who undergo surgical treatment of progressive ...
The purpose of this study is to determine freedom from ipsilateral breast recurrence occurrences in patients receiving partial breast proton radiation therapy ...
... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy, collection should be within three days prior to the end of the current ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?